RNase A Fragments with Dimethylproline
J. Am. Chem. Soc., Vol. 121, No. 49, 1999 11559
protein folding pathways that arguably may be its most
important role.
predominantly in the cis conformation in model peptides.23,30,31
Unfortunately, oxazolidine and thiazolidine compounds are acid
labile and, therefore, are not easily incorporated into pep-
tides.26,32,33 The proline analogues constrain the X-Pro peptide
group by the addition of bulky functional groups. In addition,
the presence of the heteroatom alters the ring puckering (the
dihedral angles, φ and ø) and hydrophobicity of the residue as
compared to proline, which may result in significant alterations
in the conformational properties of peptides containing oxazo-
lidine and thiazolidine proline analogues.31,34
In protein folding, numerous examples exist in which the rate-
determining step of in vitro folding is the isomerization of an
X-Pro peptide group.15,19-21 The most important purpose of
folding studies is not the characterization of the proline
isomerization processes but rather the determination of how the
sequence directs the folding process. Unfortunately, the het-
erogeneity of the X-Pro peptide groups in the unfolded state
obscures the conformational folding process and prevents
meaningful interpretation. In some cases, it has been possible
to eliminate the isomerization problem through experiments in
which the protein is rapidly unfolded, and refolding is initiated
before the X-Pro peptide groups have had time to isomerize
from their native state. This procedure has been used success-
fully to study the disulfide-intact refolding of bovine pancreatic
ribonuclease A (RNase A),22 but it severely limits the experi-
mental conditions and observation methods that can be used
and requires specialized equipment. In the case of oxidative
protein folding (beginning from the fully denatured and disulfide
reduced state), refolding rates are on a time scale similar to
that of proline isomerization, and double-jump stopped-flow
techniques are ineffective. In that situation, it has been impos-
sible to eliminate complications arising from the cis/trans
isomerization of proline peptide groups.
Clearly, the ability to constrain a peptide group to a single
unique confirmation is of considerable utility. A number of
attempts have been made to constrain the X-Pro peptide group
to a single conformation.23-31 Proline analogues such as
methanoproline24,25 and oxazolidine-4-carboxylic acid31 are very
effective at yielding high percentages of the trans conformer
while still retaining the imidic peptide bond. The most common
method of retaining a trans peptide bond, however, is simply
to replace proline with one of the other naturally occurring
amino acids, typically alanine. No such routine methods exist
for the incorporation of cis peptide groups. Among the more
successful approaches that have been used to constrain peptide
groups to the cis conformation is the use of substituted
thiazolidines and oxazolidines.23,30,31 One such analogue, 2,2-
dimethylthiazoladine-4-carboxylic acid, has been shown to exist
The pyrrolidine compound most similar to 2,2-dimethylthi-
azolidine-4-carboxylic acid is 5,5-dimethylproline (dmP).26,35
A dmP-containing dipeptide, Boc-Phe-dmP-OMe, has been
reported, and nuclear magnetic resonance (NMR) data indicated
that the peptide group was predominantly in the cis conformation
in methanol.26 Unfortunately, the results of that experiment were
not quantitative because efforts to separate the enantiomers of
dmP were unsuccessful. To ascertain the suitability of dmP for
use in peptides and proteins, we have investigated the properties
of optically pure L-dmP in aqueous solution, and we report here
the efficient separation of L-dmP from D-dmP. Since one of
our major purposes is to incorporate dmP into synthetic RNase
A and peptides derived from that protein, we have synthesized
two tripeptides, Ac-Tyr-dmP-Asn (acetylated tyrosine-5,5-
dimethylproline-asparagine, YdmPN) and Ac-Asn-dmP-Tyr
(acetylated asparagine-5,5-dimethylproline-tyrosine, NdmPY),
which correspond to residues 92-94 and 113-115, respectively,
of RNase A. In native RNase A, both of these peptides contain
cis X-Pro peptide groups.36 We also report here the solution
structure of YdmPN, cis-NdmPY, and trans-NdmpY, determined
1
by H NMR spectroscopy.
Experimental Section
Synthesis of 5,5-Dimethylproline (dmP). D,L-dmP was synthesized
at the Cornell University Biotechnology Resource Center by the method
described by Magaard et al.26
Resolution of L-dmP from D-isomer: Determination of Optical
Purity. As far as we are aware, optically pure L-dmP has not been
prepared previously. A rapid and efficient method for separating the
optical isomers of D,L-dmP was developed here, based on a method
that proved suitable to resolve the enantiomers of D,L-Pro.37 This method
is based on the differential solubility of the complexes formed between
the optical isomers of dmP and D-tartaric acid. The D,L-dmP (1.0 g/7.0
mmol, equivalent to 3.5 mmol of the L form) was dissolved in 2.0 mL
of water containing 1.05 g/7.0 mmol of D-tartaric acid at room
temperature. Then, 70 mL of absolute ethanol was added slowly with
mechanical stirring. After 24 h, a crystalline precipitate was collected
by filtration, washed with ethanol, and air-dried; yield of the L-dmP:
D-tartaric acid complex, 0.95 g (91% yield, 3.2 mmol). The dmP was
separated from the D-tartaric acid by anion-exchange chromatography
(Sigma IRA-410, Amberlite) and converted to the methyl ester using
SOCl2/MeOH.38
(17) Aronsson, G.; Brorsson, A. C.; Sahlman, L.; Jonsson, B. H. FEBS.
Lett. 1997, 411, 359.
(18) Rousseau, F.; Schymkowitz, J. W.; Sanchez, del Pino M.; Itzhaki,
L. S. J. Mol. Biol. 1998, 284, 503.
(19) Brandts, J. F.; Halvorson, H. R.; Brennan, M. Biochemistry 1975,
14, 4953.
(20) Texter, F. L.; Spencer, D. B.; Rosenstein, R.; Matthews, C. R.
Biochemistry 1992, 31, 5687.
(21) Dutta, S.; Maity, N. R.; Bhattacharyya, D. Biochim. Biophys. Acta
1997, 1343, 251.
(22) Houry, W. A.; Rothwarf, D. M.; Scheraga, H. A. Biochemistry 1994,
33, 2516.
(23) Sˇavrda, J. In Peptides 1976, Proceedings of the 14th European
Symposium, Brussels; Loffet, A., Ed.; 1976; p 653.
(24) Montelione, G. T.; Arnold, E.; Meinwald, Y. C.; Stimson, E. R.;
Denton, J. B.; Huang, S.-G.; Clardy, J.; Scheraga, H. A. J. Am. Chem. Soc.
1984, 106, 7946.
(25) Montelione, G. T.; Hughes, P.; Clardy, J.; Scheraga, H. A. J. Am.
Chem. Soc. 1986, 108, 6765.
The absolute configuration of the isomer of dmP forming the
insoluble crystalline complex with d-tartaric acid was identified as L
1
by H NMR spectroscopy of the methyl ester of the dmP isomer in
(R)-(-)-1-phenyl-2,2,2-trifluoroethanol.39 The purity of the L-dmP
(26) Magaard, V. W.; Sanchez, R. M.; Bean, J. W.; Moore, M. L.
Tetrahedron Lett. 1993, 34, 381.
(27) Zerkout, S.; Dupont, V.; Aubry, A.; Vidal, J.; Collet, A.; Vicherat,
A.; Marraud, M. Int. J. Pept. Protein Res. 1994, 44, 378.
(28) Mikhailov, D.; Daragan, V. A.; Mayo, K. H. Biophys. J. 1995, 68,
1540.
(29) Chalmers, D. K.; Marshall, G. R. J. Am. Chem. Soc. 1995, 117,
5927.
(30) Dumy, P.; Keller, M.; Ryan, D. E.; Rohwedder, B.; Wo¨hr, T.;
Mutter, M. J. Am. Chem. Soc. 1997, 119, 918.
(31) Keller, M.; Sager, C. S.; Dumy, P.; Schutkowski, M.; Fisher, G.
S.; Mutter, M. J. Am. Chem. Soc. 1998, 120, 2714.
(32) Sheehan, J. C.; Yang, D.-D. H. J. Am. Chem. Soc. 1958, 80, 1158.
(33) Wo¨hr, T.; Wahl, F.; Nefzi, A.; Rohwedder, B.; Sato, T.; Sun, X.;
Mutter, M. J. Am. Chem. Soc. 1996, 118, 9218.
(34) Frau, J.; Donoso, J.; Mun˜oz, F.; Blanco, F. G. HelV. Chim. Acta
1994, 77, 1557.
(35) Bonnett, R.; Clark, V. M.; Giddey, A.; Todd, S. A. J. Chem. Soc.
1959, 2087.
(36) Wlodawer, A.; Svensson, L. A.; Sjo¨lin, L.; Gilliland, G. L.
Biochemistry 1988, 27, 2705.
(37) Yamada, S.; Hongo, C.; Chibata, I. Agric. Biol. Chem. 1977, 41,
2413.
(38) Brenner, M.; Huber, W. HelV. Chim. Acta 1953, 36, 1109.